We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

i-Sens

Develops and manufactures self monitoring blood glucose test systems, including POCT diagnostic devices such as blood... read more Featured Products: More products

Download Mobile App





i-SENS Highlights Connected Diagnostic Systems at MEDICA 2025

By LabMedica International staff writers
Posted on 17 Nov 2025

i-SENS is presenting its latest in vitro diagnostic innovations at MEDICA 2025, highlighting connected testing platforms for clinical and near-patient applications. More...

In Hall 3, Booth B51, i-SENS is showcasing its i‑SmartCare 10 and i‑Smart 30 Pro systems alongside additional point‑of‑care (POC) analyzers intended to provide precise, efficient testing across hospital laboratories and near‑patient workflows. 

The i-SmartCare 10 is a blood gas, electrolyte, and metabolites analyzer optimized for POC use. The compact and lightweight analyzer features a high-capacity battery that supports two hours of mobile, continuous testing, plus an easy-to-manage all-in-one cartridge system. The i-Smart 30 Pro is an electrolyte analyzer that measures Na+, K+, and CI- concentrations, reporting results in 35 seconds on a color screen. Added benefits include an all-in-one cartridge that can be used for four weeks, battery power for two hours, and fast and error-free data entry using a barcode scanner.

The company will also feature the CareSens Air Continuous Glucose Monitoring System (CGMS). CareSens Air CGM is a 15-day, all-in-one sensor that provides real-time glucose monitoring, with data easily accessible through the CareSens app. The sensor is just 5 mm thick and weighs only 4.5 g.. Also on display at the i-SENS booth is a wide variety of CareSens Blood Glucose Monitoring System (BGMS) models, designed for accuracy, ease of use, and reliability in diverse care environments.

i-SENS’s participation at MEDICA 2025 underscores the company’s commitment to advancing smart, connected diagnostics that enhance clinical decision-making and improve patient outcomes. By continuously developing innovative and accessible solutions, i-SENS strives to support healthcare professionals and contribute to a more connected, data-driven future of care.

Related Links:
i-SENS


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The new analysis of blood samples links specific protein patterns to five- and ten-year mortality risk (Photo courtesy of Adobe Stock)

Blood Protein Profiles Predict Mortality Risk for Earlier Medical Intervention

Elevated levels of specific proteins in the blood can signal increased risk of mortality, according to new evidence showing that five proteins involved in cancer, inflammation, and cell regulation strongly... Read more

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: The SMART-ID Assay delivers broad pathogen detection without the need for culture (Photo courtesy of Scanogen)

Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples

Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.